Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Khaldoun George Tarakji, MD, MPH, is a staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He is board-certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology and Clinical Electrophysiology. His specialty areas include: atrial and ventricular arrhythmias including atrial fibrillation and catheter ablation for treatment of these arrhythmias including pulmonary vein isolation. He also specializes in device therapy including device and lead extraction and the implantation of pacemakers, implantable defibrillators (ICDs), and biventricular pacemakers and ICDs.
Dr. Tarakji received his medical degree from the University of Damascus, Syria. After graduation, he relocated to the United States where he worked as a research associate in cardiovascular medicine at Wayne State University in Detroit, Michigan.
Dr. Tarakji came to Cleveland Clinic in 2000 as a research fellow in the Department of Cardiovascular Medicine. From 2001 through 2004 he was a resident in Internal Medicine at Cleveland Clinic. After completing his residency, he remained at Cleveland Clinic as a clinical associate in the Section of Cardiac Electrophysiology, department of Cardiovascular Medicine. In 2009 Dr. Tarakji completed a fellowship in cardiovascular medicine, followed by a fellowship in electrophysiology, which he completed in 2011 and both at the Cleveland Clinic. He was the recipient of many awards including the Ohio ACC chapter fellows research award in 2006, the Cardiothoracic Annual Research award in 2006, the Cash Memorial Award for clinical research in 2007, and the Irving Dawson Award For Clinical Excellence in 2009 in the department of Cardiovascular Medicine. In 2010 he received a Master’s degree in Public Health from Cleveland State University. He was appointed to the medical staff in 2011.
Dr. Tarakji has authored and co-authored many articles in leading scientific journals including Circulation, Journal of American Medical Association (JAMA), Journal of the American College of Cardiology, and Heart Rhythm. He has also presented at several national and international medical meetings. He is a member of the American Heart Association, the American College of Cardiology, the Heart Rhythm Society and the Honor Society for Collegiate Schools of Business.
In his leisure time, Dr. Tarakji enjoys photography, biking and hiking. He also is an accomplished classical guitarist, graduating with an “Excellent” rating from the Syrian Ministry of Culture National Conservatory for Classical Music.
Pulmonary vein isolation for atrial fibrillation, catheter ablation for both atrial and ventricular arrhythmia, device therapy including the implantation and extraction of cardiac pacemakers, implantable cardiovascular defibrillators (ICDs), cardiac resynchronization therapy (CR-D).
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/27/2015, Dr. Tarakji has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.